Skip to main content
. 2018 Mar 11;2018:1705478. doi: 10.1155/2018/1705478

Table 3.

The distributions of SIRPB1 and TMEM91 CNVs in AITD patients and controls.

Gene/CNV Case, n (%)
N = 158
Control, n (%)
N = 181
p value
SIRPB1
 Normal 138 (87.34) 174 (96.13)
 Loss 9 (5.70) 6 (3.32) 0.288
 Gain 11 (6.96) 1 (0.55) 0.001
TMEM91
 Normal 148 (93.67) 176 (97.24)
 Loss 9 (5.70) 4 (2.21) 0.095
 Gain 1 (0.63) 1 (0.55) 1.000

The frequency of CNV gain for SIRPB1 gene in the case group was significantly higher than that in the control group.